Erratum: Mutations in the cytoplasmic domain of the newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicity (Journal of Virology (2013) 87:18 (10083–10093) Doi:10.1128/JVI.01446-13);Mutations in the cytoplasmic domain of the newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicity

Journal of Virology

Volumn 87, Issue 18, 2013, Pages 10083-10093

  Sama, Sweety ^a   Khattar, Sunil K ^a   Paldurai, Anandan ^a   Palaniyandi, Senthilkumar ^a   Zhu, Xiaoping ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LEUCINE; MUTANT PROTEIN; TYROSINE; VIRUS FUSION PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOPLASMIC TAIL DOMAIN; EMBRYO; GENE DELETION; GENE DISRUPTION; HUMAN; HUMAN CELL; KINETICS; MUTATIONAL ANALYSIS; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PARAMYXOVIRUS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; VERO CELL; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS VIRULENCE;

NEWCASTLE DISEASE VIRUS;

EID: 84883306375     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01857-19     Document Type: Erratum

References (61)

1. Alexander DJ. 2000. Newcastle disease and other avian paramyxoviruses. Rev. Sci. Tech. 19:443-462.
2. Samal SK. 2011. Newcastle disease and related avian paramyxoviruses, p 69-114. In Samal SK (ed), The biology of paramyxoviruses. Caister Academic Press, Norfolk, United Kingdom.
3. Aldous EW, Alexander DJ. 2001. Detection and differentiation of Newcastle disease virus (avian paramyxovirus type 1). Avian Pathol. 30:117-128.
4. Lamb RA, Kolakofsky D. 2001. Paramyxoviridae: the viruses and their replication, p 1305-1340. In Knipe DM, Howley PM (ed), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Chen L, Gorman JJ, McKimm-Breschkin J, Lawrence LJ, Tulloch PA, Smith BJ, Colman PM, Lawrence MC. 2001. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure 9:255-266.
6. Iorio RM, Field GM, Sauvron JM, Mirza AM, Deng R, Mahon PJ, Langedijk JP. 2001. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75:1918-1927.
7. Lamb RA, Paterson RG, Jardetzky TS. 2006. Paramyxovirus membrane fusion: lessons from the F andHNatomic structures. Virology 344:30-37.
8. Morrison TG. 2003. Structure and function of a paramyxovirus fusion protein. Biochim. Biophys. Acta 1614:73-84.
9. Lamb RA. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
10. Nagai Y, Hamaguchi M, Toyoda T. 1989. Molecular biology of Newcastle disease virus. Prog. Vet. Microbiol. Immunol. 5:16-64.
11. Baker KA, Dutch RE, Lamb RA, Jardetzky TS. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3:309-319.
12. Russell CJ, Kantor KL, Jardetzky TS, Lamb RA. 2003. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J. Cell Biol. 163:363-374.
13. Carr CM, Kim PS. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
14. Collins PL, Mottet G. 1991. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 72:3095-3101.
15. Dutch RE. 2010. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 6:e1000881. doi:10.1371/journal.ppat.1000881.
16. Joshi SB Dutch RE, Lamb RA. 1998. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 248:20-34.
17. Weissenhorn W, Calder LJ, Wharton SA, Skehel JJ, Wiley DC. 1998. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc. Natl. Acad. Sci. U. S. A. 95:6032-6036.
18. Zhu J, Zhang CW, Qi Y, Tien P, Gao GF. 2002. The fusion protein core of measles virus forms stable coiled-coil trimer. Biochem. Biophys. Res. Commun. 299:897-902.
19. Ayllon J, Villar E, Munoz-Barroso I. 2010. Mutations in the ectodomain of newcastle disease virus fusion protein confer a hemagglutininneuraminidase-independent phenotype. J. Virol. 84:1066-1075.
20. Dolganiuc V, McGinnes L, Luna EJ, Morrison TG. 2003. Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J. Virol. 77:12968-12979.
21. Neyt C, Geliebter J, Slaoui M, Morales D, Meulemans G, Burny A. 1989. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J. Virol. 63:952-954.
22. Samal S, Khattar SK, Kumar S, Collins PL, Samal SK. 2012. Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicity. J. Virol. 86:2501-2511.
23. Samal S, Kumar S, Khattar SK, Samal SK. 2011. A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity. J. Gen. Virol. 92:2333-2338.
24. Sergel TA, McGinnes LW, Morrison TG. 2001. Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein. J. Virol. 75:7934-7943.
25. Aguilar HC, Matreyek KA, Choi DY, Filone CM, Young S, Lee B. 2007. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J. Virol. 81:4520-4532.
26. Bagai S, Lamb RA. 1996. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:73-84.
27. Emerson V, Haller C, Pfeiffer T, Fackler OT, Bosch V. 2010. Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes. Retrovirology 7:43.
28. Fan Z, Grantham ML, Smith MS, Anderson ES, Cardelli JA, Muggeridge MI. 2002. Truncation of herpes simplex virus type 2 glycoprotein B increases its cell surface expression and activity in cell-cell fusion, but these properties are unrelated. J. Virol. 76:9271-9283.
29. Oomens AG, Bevis KP, Wertz GW. 2006. The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J. Virol. 80:10465-10477.
30. Saha K, Yan H, Nelson JA, Zerhouni-Layachi B. 2005. Infection of human and non-human cells by a highly fusogenic primary CD4-independent HIV-1 isolate with a truncated envelope cytoplasmic tail. Virology 337:30-44.
31. Tong S, Li M, Vincent A, Compans RW, Fritsch E, Beier R, Klenk C, Ohuchi M, Klenk HD. 2002. Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. Virology 301:322-333.
32. Vzorov AN, Weidmann A, Kozyr NL, Khaoustov V, Yoffe B, Compans RW. 2007. Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection. Retrovirology. 4:94.
33. Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA. 2005. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol. 79:12231-12241.
34. Yao Q, Compans RW. 1995. Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J. Virol. 69:7045-7053.
35. Aroeti B, Kosen PA, Kuntz ID, Cohen FE, Mostov KE. 1993. Mutational and secondary structural analysis of the basolateral sorting signal of the polymeric immunoglobulin receptor. J. Cell Biol. 123:1149-1160.
36. Bonifacino JS, Dell'Angelica EC. 1999. Molecular bases for the recognition of tyrosine-based sorting signals. J. Cell Biol. 145:923-926.
37. Ball JM, Mulligan MJ, Compans RW. 1997. Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain. AIDS Res. Hum. Retroviruses 13:665-675.
38. Brewer CB, Roth MG. 1991. A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin. J. Cell Biol. 114:413-421.
39. Weise C, Erbar S, Lamp B, Vogt C, Diederich S, Maisner A. 2010. Tyrosine residues in the cytoplasmic domains affect sorting and fusion activity of the Nipah virus glycoproteins in polarized epithelial cells. J. Virol. 84:7634-7641.
40. Bello V, Goding JW, Greengrass V, Sali A, Dubljevic V, Lenoir C, Trugnan G, Maurice M. 2001. Characterization of a di-leucine-based signal in the cytoplasmic tail of the nucleotide-pyrophosphatase NPP1 that mediates basolateral targeting but not endocytosis. Mol. Biol. Cell 12:3004-3015.
41. Hunziker W, Fumey C. 1994. A di-leucine motif mediates endocytosis and basolateral sorting of macrophage IgG Fc receptors in MDCK cells. EMBO J. 13:2963-2969.
42. Dylla DE, Michele DE, Campbell KP, McCray PB, Jr. 2008. Basolateral entry and release of New and Old World arenaviruses from human airway epithelia. J. Virol. 82:6034-6038.
43. Javier RT. 2008. Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene 27:7031-7046.
44. Runkler N, Dietzel E, Carsillo M, Niewiesk S, Maisner A. 2009. Sorting signals in the measles virus wild-type glycoproteins differently influence virus spread in polarized epithelia and lymphocytes. J. Gen. Virol. 90: 2474-2482.
45. de Leeuw O, Peeters B. 1999. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J. Gen. Virol. 80:131-136.
46. Krishnamurthy S, Huang Z, Samal SK. 2000. Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278: 168-182.
47. Paldurai A, Kumar S, Nayak B, Samal SK. 2010. Complete genome sequence of highly virulent neurotropic Newcastle disease virus strain Texas GB. Virus Genes 41:67-72.
48. Sergel T, Morrison TG. 1995. Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology 210:264-272.
49. Kohn A. 1965. Polykaryocytosis induced by Newcastle disease virus in monolayers of animal cells. Virology 26:228-245.
50. Branigan PJ, Day ND, Liu C, Gutshall LL, Melero JA, Sarisky RT, Del Vecchio AM. 2006. The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion. J. Gen. Virol. 87:395-398.
51. Cathomen T, Naim HY, Cattaneo R. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1224-1234.
52. Barry C, Duncan R. 2009. Multifaceted sequence-dependent and-independent roles for reovirus FAST protein cytoplasmic tails in fusion pore formation and syncytiogenesis. J. Virol. 83:12185-12195.
53. Kim SH, Yan Y, Samal SK. 2009. Role of the cytoplasmic tail amino acid sequences of Newcastle disease virus hemagglutinin-neuraminidase protein in virion incorporation, cell fusion, and pathogenicity. J. Virol. 83: 10250-10255.
54. Zingler K, Littman DR. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. J. Virol. 67: 2824-2831.
55. Zokarkar A, Lamb RA. 2012. The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit. J. Virol. 86:2600-2609.
56. Popa A, Pager CT, Dutch RE. 2011. C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein. Biochemistry 50:945-952.
57. Seth S, Vincent A, Compans RW. 2003. Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J. Virol. 77:167-178.
58. Waning DL, Russell CJ, Jardetzky TS, Lamb RA. 2004. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc. Natl. Acad. Sci. U. S. A. 101:9217-9222.
59. Dutch RE, Lamb RA. 2001. Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J. Virol. 75:5363-5369.
60. Moll M, Pfeuffer J, Klenk HD, Niewiesk S, Maisner A. 2004. Polarized glycoprotein targeting affects the spread of measles virus in vitro and in vivo. J. Gen. Virol. 85:1019-1027.
61. Tashiro M, Seto JT, Choosakul S, Yamakawa M, Klenk HD, Rott R. 1992. Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice. Virology 187: 413-422.